Cargando…

Longitudinal cognitive performance of Alzheimer's disease neuropathological subtypes

INTRODUCTION: Alzheimer's disease (AD) neuropathological subtypes (limbic predominant [lpAD], hippocampal sparing [HpSpAD], and typical [tAD]), defined by relative neurofibrillary tangle (NFT) burden in limbic and cortical regions, have not been studied in prospectively characterized epidemiolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Uretsky, Madeline, Gibbons, Laura E., Mukherjee, Shubhabrata, Trittschuh, Emily H., Fardo, David W., Boyle, Patricia A., Keene, C. Dirk, Saykin, Andrew J., Crane, Paul K., Schneider, Julie A., Mez, Jesse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474122/
https://www.ncbi.nlm.nih.gov/pubmed/34604500
http://dx.doi.org/10.1002/trc2.12201
_version_ 1784575150046314496
author Uretsky, Madeline
Gibbons, Laura E.
Mukherjee, Shubhabrata
Trittschuh, Emily H.
Fardo, David W.
Boyle, Patricia A.
Keene, C. Dirk
Saykin, Andrew J.
Crane, Paul K.
Schneider, Julie A.
Mez, Jesse
author_facet Uretsky, Madeline
Gibbons, Laura E.
Mukherjee, Shubhabrata
Trittschuh, Emily H.
Fardo, David W.
Boyle, Patricia A.
Keene, C. Dirk
Saykin, Andrew J.
Crane, Paul K.
Schneider, Julie A.
Mez, Jesse
author_sort Uretsky, Madeline
collection PubMed
description INTRODUCTION: Alzheimer's disease (AD) neuropathological subtypes (limbic predominant [lpAD], hippocampal sparing [HpSpAD], and typical [tAD]), defined by relative neurofibrillary tangle (NFT) burden in limbic and cortical regions, have not been studied in prospectively characterized epidemiological cohorts with robust cognitive assessments. METHODS: Two hundred ninety‐two participants with neuropathologically confirmed AD from the Religious Orders Study and Memory and Aging Project were categorized by neuropathological subtype based on previously specified diagnostic criteria using quantitative regional NFT counts. Rates of cognitive decline were compared across subtypes using linear mixed‐effects models that included subtype, time, and a subtype–time interaction as predictors and four cognitive domain factor scores (memory, executive function, language, visuospatial) and a global score as outcomes. To assess if memory was relatively preserved in HpSpAD, non‐memory factor scores were included as covariates in the mixed‐effects model with memory as the outcome. RESULTS: There were 57 (20%) with lpAD, 22 (8%) with HpSpAD and 213 (73%) with tAD. LpAD died significantly later than the participants with tAD (2.4 years, P = .01) and with HpSpAD (3.8 years, P = .03). Compared to tAD, HpSpAD, but not lpAD, performed significantly worse in all cognitive domains at the time of initial impairment and declined significantly faster in memory, language, and globally. HpSpAD did not have relatively preserved memory performance at any time point. CONCLUSION: The relative frequencies of AD neuropathological subtypes in an epidemiological sample were consistent with a previous report in a convenience sample. People with HpSpAD decline rapidly, but may not have a memory‐sparing clinical syndrome. Cohort‐specific differences in regional tau burden and comorbid neuropathology may explain the lack of clinicopathological correlation.
format Online
Article
Text
id pubmed-8474122
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-84741222021-10-01 Longitudinal cognitive performance of Alzheimer's disease neuropathological subtypes Uretsky, Madeline Gibbons, Laura E. Mukherjee, Shubhabrata Trittschuh, Emily H. Fardo, David W. Boyle, Patricia A. Keene, C. Dirk Saykin, Andrew J. Crane, Paul K. Schneider, Julie A. Mez, Jesse Alzheimers Dement (N Y) Research Articles INTRODUCTION: Alzheimer's disease (AD) neuropathological subtypes (limbic predominant [lpAD], hippocampal sparing [HpSpAD], and typical [tAD]), defined by relative neurofibrillary tangle (NFT) burden in limbic and cortical regions, have not been studied in prospectively characterized epidemiological cohorts with robust cognitive assessments. METHODS: Two hundred ninety‐two participants with neuropathologically confirmed AD from the Religious Orders Study and Memory and Aging Project were categorized by neuropathological subtype based on previously specified diagnostic criteria using quantitative regional NFT counts. Rates of cognitive decline were compared across subtypes using linear mixed‐effects models that included subtype, time, and a subtype–time interaction as predictors and four cognitive domain factor scores (memory, executive function, language, visuospatial) and a global score as outcomes. To assess if memory was relatively preserved in HpSpAD, non‐memory factor scores were included as covariates in the mixed‐effects model with memory as the outcome. RESULTS: There were 57 (20%) with lpAD, 22 (8%) with HpSpAD and 213 (73%) with tAD. LpAD died significantly later than the participants with tAD (2.4 years, P = .01) and with HpSpAD (3.8 years, P = .03). Compared to tAD, HpSpAD, but not lpAD, performed significantly worse in all cognitive domains at the time of initial impairment and declined significantly faster in memory, language, and globally. HpSpAD did not have relatively preserved memory performance at any time point. CONCLUSION: The relative frequencies of AD neuropathological subtypes in an epidemiological sample were consistent with a previous report in a convenience sample. People with HpSpAD decline rapidly, but may not have a memory‐sparing clinical syndrome. Cohort‐specific differences in regional tau burden and comorbid neuropathology may explain the lack of clinicopathological correlation. John Wiley and Sons Inc. 2021-09-27 /pmc/articles/PMC8474122/ /pubmed/34604500 http://dx.doi.org/10.1002/trc2.12201 Text en © 2021 The Authors. Alzheimer's & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals, Inc. on behalf of Alzheimer's Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Uretsky, Madeline
Gibbons, Laura E.
Mukherjee, Shubhabrata
Trittschuh, Emily H.
Fardo, David W.
Boyle, Patricia A.
Keene, C. Dirk
Saykin, Andrew J.
Crane, Paul K.
Schneider, Julie A.
Mez, Jesse
Longitudinal cognitive performance of Alzheimer's disease neuropathological subtypes
title Longitudinal cognitive performance of Alzheimer's disease neuropathological subtypes
title_full Longitudinal cognitive performance of Alzheimer's disease neuropathological subtypes
title_fullStr Longitudinal cognitive performance of Alzheimer's disease neuropathological subtypes
title_full_unstemmed Longitudinal cognitive performance of Alzheimer's disease neuropathological subtypes
title_short Longitudinal cognitive performance of Alzheimer's disease neuropathological subtypes
title_sort longitudinal cognitive performance of alzheimer's disease neuropathological subtypes
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474122/
https://www.ncbi.nlm.nih.gov/pubmed/34604500
http://dx.doi.org/10.1002/trc2.12201
work_keys_str_mv AT uretskymadeline longitudinalcognitiveperformanceofalzheimersdiseaseneuropathologicalsubtypes
AT gibbonslaurae longitudinalcognitiveperformanceofalzheimersdiseaseneuropathologicalsubtypes
AT mukherjeeshubhabrata longitudinalcognitiveperformanceofalzheimersdiseaseneuropathologicalsubtypes
AT trittschuhemilyh longitudinalcognitiveperformanceofalzheimersdiseaseneuropathologicalsubtypes
AT fardodavidw longitudinalcognitiveperformanceofalzheimersdiseaseneuropathologicalsubtypes
AT boylepatriciaa longitudinalcognitiveperformanceofalzheimersdiseaseneuropathologicalsubtypes
AT keenecdirk longitudinalcognitiveperformanceofalzheimersdiseaseneuropathologicalsubtypes
AT saykinandrewj longitudinalcognitiveperformanceofalzheimersdiseaseneuropathologicalsubtypes
AT cranepaulk longitudinalcognitiveperformanceofalzheimersdiseaseneuropathologicalsubtypes
AT schneiderjuliea longitudinalcognitiveperformanceofalzheimersdiseaseneuropathologicalsubtypes
AT mezjesse longitudinalcognitiveperformanceofalzheimersdiseaseneuropathologicalsubtypes